Key statistics
Key statistics
- 700+ employees globally
- 4 sites (3 in India, 1 in US)
- 8 biosimilars commercialized in 5 years
- Delivered 30+ projects using EnzeneX®
- 10 months from gene to phase 1
- 8 weeks onboarding
- Up to 50% reduction in COGS and carbon footprint using EnzeneX®
- 10 times higher productivity and improved quality for complex proteins using EnzeneX®
- EU-GMP certified GMP sites in India
- USDA-FDA designed GMP facility in US
The most advanced innovation is only one step away.
From discovery to commercial supply, an Enzene partnership brings a new way of thinking about biologics.
Let’s discuss your challenge or project.